Track topics on Twitter Track topics that are important to you
VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 06/19/17 -- Quadron Cannatech Corporation (the "Company" or "Quadron") - (CSE: QCC)(CSE: QCC.CN)(CNSX: QCC) is pleased to announce that effective June 16, 2017 at closing trading, the Company has been added to the CSE Composite Index.
Additionally, the CSE has recognized CEO Rosy Mondin's experience in the Cannabis sector and the two parties have been collaborating on marketing efforts to raise awareness of their respective businesses. Most recently, Rosy spoke at two CSE events in Toronto and Montreal and will continue to participate in upcoming events.
Rosy Mondin, President and CEO of Quadron commented, "We are pleased to not only be added to the Index but also to be recognized by the CSE as a leader in Canadian-made automated botanical extraction and processing solutions. This is allowing us to market with the CSE as a featured industry speaker at CSE events across Canada. The CSE is an excellent exchange for entrepreneurs, liquidity and industry participation and we will continue to build our business on this strong foundation."
The CSE Composite index is comprised of shares of listed companies that meet market capitalization, trading and seasoning criteria established by the exchange.
About Quadron: Quadron focuses on ancillary equipment, products and services for the authorized cannabis industry, providing automated extraction and processing solutions, and sales of end user delivery solutions such as vape pens, capsules and other safer consumption solutions for patients.
For more information, visit: www.quadroncannatech.com
On behalf of the Board of Directors of QUADRON CANNATECH CORPORATION
Rosy Mondin, President and CEO
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
Statements included in this announcement, including statements concerning our plans, intentions and expectations, which are not historical in nature are intended to be, and are hereby identified as "forward-looking statements". Forward-looking statements may be identified by words including "anticipates", "believes", "intends", "estimates", "expects" and similar expressions. The Company cautions readers that forward-looking statements, including without limitation those relating to the Company's future operations and business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements.Contacts: Quadron Cannatech Corporation Rosy Mondin President and CEO Investor Relations Contact: KIN Communications Inc. Caleb Jeffries, VP, Investor Relations 1-866-684-6730 NEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...